NJ-OPEX
OPEX® Corporation, a global leader in Next Generation Automation for almost 50 years, today announced the launch of its newest automated sorting and order retrieval solutions―OPEX Sure Sort® X with OPEX Xtract™. These innovative technologies were officially unveiled by company leadership at MODEX 2024, the largest manufacturing and supply chain trade event, held this year at the Georgia World Congress Center in Atlanta.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240311187962/en/
OPEX® Sure Sort® X with OPEX Xtract™ (Photo: Business Wire)
OPEX Sure Sort X represents the next generation of high-speed, automated sorting. It is the most robust industrial sorting solution available in the market, unmatched in terms of its compact footprint, performance rates, and cost-effectiveness. This universal system can handle nearly 100% of customer-sortable items weighing up to 20 pounds (9 kg), and sort items into a configurable array of mixed bin sizes and types.
When Sure Sort X is paired with Xtract―OPEX’s revolutionary new automated order retrieval system―the task of retrieving totes and transferring their contents into shipping containers is now fully automated, as well. The result is a one-touch solution that can eliminate the need to manually sort and transfer boxes downstream.
"OPEX remains dedicated to innovations that align with the evolving demands of the market," stated Alex Stevens, President of Warehouse Automation at OPEX. "We have received feedback from our customers that they want one integrated solution to sort, retrieve, and automatically get the product into its final container. Our new solutions, Sure Sort X and Xtract, are a response to those requests. This cutting-edge technology is designed to automate multiple manual tasks with a simple, one-touch solution.”
Developed based on feedback from the international business community, Sure Sort X applies OPEX Corporation’s innovative, industry-leading Sure Sort technology, introduced in 2017. With its enhanced product handling capabilities, Sure Sort X is the single most versatile and configurable sorting solution available. It can handle items 60 percent smaller, nearly 20 percent larger, and up to 300 percent heavier than its predecessor, all while maintaining a consistent throughput of up to 2,100 items per hour.
The system’s iBOT® delivery vehicles utilize sophisticated motion algorithms that allow them to maneuver throughout the system efficiently, with the ability to change destination in real time while in transit. These iBOTs can drive in and out of the system while Sure Sort X continues to run, ensuring the highest level of uptime and availability. In addition, Sure Sort X can operate in both chilled and ambient environments. Installation can occur in as little as one week.
OPEX Xtract can be added to any Sure Sort X system by introducing retrieval iBOTs to work in conjunction with the traditional sortation iBOTs found in Sure Sort X. Xtract iBOTs move in a loop that has both horizontal and vertical segments within the Sure Sort X aisle, and can handle up to 200 extracted totes per hour. All of the iBOTs are self-charging and can easily be added to or removed from the system.
The system can retrieve standard totes or can be outfitted with Xtract totes, which are uniquely designed to transport items from the sort location to any available roller, v-chute, transfer (RVT) module. If these totes are used, once all products for a relevant order have been deposited into the Xtract totes, each tote is retrieved and transported to the RVT module, where the tote door opens and releases the items into the final shipping box or order container.
Soon after its unveiling in the US at MODEX, Sure Sort X will make its European debut at the LogiMAT expo in Stuttgart, Germany, on March 19, 2024, at the OPEX exhibit in Hall 7, Stand 7D53.
Sure Sort X and Xtract join the existing Warehouse Automation portfolio at OPEX, which includes Sure Sort®—the industry-leading, high-speed, small-item robotic sorting system; Perfect Pick®, a robotic goods-to-person picking solution that dramatically improves speed, efficiency, and reliability, and Infinity®―the most advanced goods-to-person solution available in warehouse automation. All are custom configured for each client and designed to completely transform supply chain infrastructure.
For nearly five decades, OPEX Corporation has served as a trusted partner, collaborating closely with clients to develop customized, scalable solutions that transform how business is conducted. OPEX continuously reimagines automation technology to help clients solve their most significant business challenges, today and in the future.
About OPEX
OPEX® Corporation is a global leader in Next Generation Automation, providing innovative, unique solutions for warehouse, document and mail automation. With headquarters in Moorestown, NJ, USA—and facilities in Pennsauken, NJ; Plano, TX; France; Germany; Switzerland; the United Kingdom; and Australia—OPEX has more than 1,600 employees who are continuously reimagining and delivering customized, scalable technology solutions that solve the business challenges of today and in the future.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240311187962/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biocytogen and Acepodia Expand Collaboration Through Option-based Evaluation Framework for First-in-Class Bispecific and Dual-Payload ADCs (BsAD2C)9.1.2026 13:00:00 CET | Press release
Expanded collaboration builds on Acepodia and Biocytogen’s recent co-development efforts to evaluate selected bispecific antibody and dual-payload ADC programs Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315) and Acepodia (6976:TT), today announced that the companies have entered into an option and license agreement designed to enable the structured evaluation of bispecific antibody-drug conjugate (BsADC) programs to further advance the development of dual-payload bispecific antibody-drug conjugates (BsAD2Cs). The agreement grants Acepodia an option to obtain an exclusive worldwide license from Biocytogen for two BsADC programs. Under the terms of the agreement, Biocytogen is eligible to receive an upfront option fee and, upon Acepodia’s exercise of the option, additional payments including option exercise fees, development, regulatory, and commercial milestone payments, as well as royalties on future product sales. The financial terms of the agreem
Blockstream Capital Partners Announces Strategic Acquisition of Derivatives Trading Team from Numeus Group, Leveraging Strategic Partnership with Komainu9.1.2026 11:08:00 CET | Press release
Blockstream Capital Partners (“BCP”) today announced that it has entered into a strategic agreement to acquire a division within Numeus Group’s digital asset trading and investment business. The transaction includes the absorption of select Bitcoin focused trading strategies with a focus on yield generation as well as a ten person derivatives trading team led by Chief Investment Officer Deepak Gulati, a specialist in volatility and derivatives markets. Deepak Gulati, appointed Co-Chief Investment Officer of Blockstream Capital Management alongside Rodrigo Rodriguez, previously served as Global Head of Proprietary Trading at JPMorgan, before founding Argentiere Capital, a multibillion-dollar volatility-focused hedge fund. With a thesis that derivatives would drive Bitcoin and digital asset market maturity, he co-founded Numeus Group in 2021 to develop institutional-grade trading, risk management and market-structure capabilities. Komainu, an existing BCP strategic investment, has played
Autel Unveils Strategic Shift at CES 2026: Building the AI-Powered Infrastructure of Future Cities9.1.2026 10:44:00 CET | Press release
At the Consumer Electronics Show (CES), Autel Energy is presenting its latest AI-driven smart hardware and software systems for the future of intelligent urban operations. This year’s showcase highlights Autel’s shift from AI concept validation to scenario-based engineering deployment, emphasizing closed-loop execution across real-world infrastructure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260101511436/en/ Autel Energy New Product Debut at CES 2026 Focusing on two key domains — Smart Energy and Smart Inspection — the company is unveiling a range of new products. In Smart Energy, Autel is introducing V2G (Vehicle-to-Grid) AC charger for homes and DC charging solution for fleets, strengthening its multi-tier energy touchpoint strategy from households to commercial operations. Live demonstrations at the booth will feature a smart charging robot showcasing automated plug-in capabilities. In Smart Inspection, Autel will
Allianz and Anthropic Forge Global Partnership to Advance Responsible AI in Insurance9.1.2026 10:00:00 CET | Press release
Anthropic’s safety-first AI meets Allianz's dedication to customer centricity, stakeholder trust, and regulatory excellenceThree focus areas of the partnership: workforce empowerment, operations automation through agentic AI, and regulatory compliance Allianz SE and Anthropic today announced a global partnership to accelerate the adoption of responsible Artificial Intelligence (AI) at Allianz. The collaboration centers on three transformative projects within Allianz Group designed to empower Allianz employees and accelerate operations, while setting new benchmarks for accuracy. “With this partnership, Allianz is taking a decisive step to address critical AI challenges in insurance. Anthropic’s focus on safety and transparency complements our strong dedication to customer excellence and stakeholder trust. Together, we are building solutions that prioritize what matters most to our customers while setting new standards for innovation and resilience,” said Oliver Bäte, CEO of Allianz SE.
MRM Health Secures FDA IND Clearance to Launch its Phase 2b Trial of MH002 in Mild-to-Moderate Ulcerative Colitis9.1.2026 07:00:00 CET | Press release
MH002 is currently the most advanced Live Biotherapeutic Product (LBP) based on a rationally-designed combination of disease specific bacteria (microbial consortia), for the treatment of inflammatory bowel diseases (IBD) STARFISH-UC Phase 2b trial is designed to confirm MH002’s early efficacy signals and favorable safety observed in Phase 2a studies MRM Health NV, a clinical-stage biopharmaceutical company pioneering microbiome-based therapeutics for inflammatory diseases and immune-oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance of its Investigational New Drug (IND) application for its lead program MH002. This enables the initiation of the STARFISH-UC Phase 2b clinical trial in patients with mild-to-moderate ulcerative colitis, marking a significant step forward in the development of next-generation therapies for inflammatory bowel diseases (IBD). About the STARFISH-UC Phase 2b Trial The STARFISH-UC trial is a randomized, double-blind,
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
